Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Siponimod
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Siponimod 250microgram tablets
0802040BBAAAAAA
|
Siponimod | Siponimod | Malignant Disease and Immunosuppression | 3 |
|
Mayzent 0.25mg tablets
0802040BBBBAAAA
|
Mayzent | Siponimod | Malignant Disease and Immunosuppression | No data available |
|
Mayzent 1mg tablets
0802040BBBBACAC
|
Mayzent | Siponimod | Malignant Disease and Immunosuppression | No data available |
|
Mayzent 2mg tablets
0802040BBBBABAB
|
Mayzent | Siponimod | Malignant Disease and Immunosuppression | No data available |
|
Siponimod 1mg tablets
0802040BBAAACAC
|
Siponimod | Siponimod | Malignant Disease and Immunosuppression | No data available |
|
Siponimod 2mg tablets
0802040BBAAABAB
|
Siponimod | Siponimod | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.